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disentangle recent population history in the widely-used 1000 Genomes Project 24 reference panel, with an emphasis on populations underrepresented in medical studies. 25
To examine the transferability of single-ancestry GWAS, we used published summary 26 statistics to calculate polygenic risk scores for six well-studied traits and diseases. We 27 identified directional inconsistencies in all scores; for example, height is predicted to 28 decrease with genetic distance from Europeans, despite robust anthropological 29 evidence that West Africans are as tall as Europeans on average. To gain deeper 30 quantitative insights into GWAS transferability, we developed a complex trait 31 coalescent-based simulation framework considering effects of polygenicity, causal allele 32 frequency divergence, and heritability. As expected, correlations between true and 33 inferred risk were typically highest in the population from which summary statistics were 34 derived. We demonstrated that scores inferred from European GWAS were biased by 35 genetic drift in other populations even when choosing the same causal variants, and 36 that biases in any direction were possible and unpredictable. This work cautions that 37 5 of demography, then we expect that modeling sub-continental ancestry may enable 92 their improved detection in admixed populations. 93
94
In this study, we explore the impact of population diversity on the landscape of variation 95 underlying human traits. We infer demographic history for the global populations in the 96 1000 Genomes Project, focusing particularly on admixed populations from the 97 Americas, which are under represented in medical genetic studies 4 . We disentangle 98 local ancestry to infer the ancestral origins of these populations. We link this work to 99 ongoing efforts to improve study design and disease variant discovery by quantifying 100 biases in clinical databases and GWAS in diverse and admixed populations. These 101 biases have a striking impact on genetic risk prediction; for example, a previous study 102 calculated polygenic risk scores for schizophrenia in East Asians and Africans based on 103 GWAS summary statistics derived from a European cohort, and found that prediction 104 accuracy was reduced by more than 50% in non-European populations 53 . To 105 disentangle the role of demography on polygenic risk prediction derived from single-106 ancestry GWAS, we designed a novel coalescent-based simulation framework reflecting 107 modern human population history and show that polygenic risk scores derived from 108
European GWAS are biased when applied to diverged populations. Specifically, we 109 identify reduced variance in risk prediction with increasing divergence from Europe 110 6 the need for the inclusion of more diverse populations in GWAS as well as genetic risk 114 prediction methods improving transferability across populations. 115 116 Material and Methods 117
Ancestry deconvolution 118
We used the phased haplotypes from the 1000 Genomes consortium. We phased 119 reference haplotypes from 43 Native American samples from 54 inferred to have > 0.99 120 Native ancestry in ADMIXTURE using SHAPEIT2 (v2.r778) 55 , then merged the 121 haplotypes using scripts made publicly available. These combined phased haplotypes 122 were used as input to the PopPhased version of RFMix v1.5.4 56 with the following flags: 123 -w 0.2, -e 1, -n 5, --use-reference-panels-in-EM, --forward-backward. The node size of 5 124 was selected to reduce bias in random forests resulting from unbalanced reference 125 panel sizes (AFR panel N=504, EUR panel N=503, and NAT panel N=43). We used the 126 default minimum window size of 0.2 cM to enable model comparisons with previously 127 inferred models using Tracts 57 . We used 1 EM iteration to improve the local ancestry 128 calls without substantially increasing computational complexity. We used the reference 129 panel in the EM to take better advantage of the Native American ancestry tracts from 130 as seen previously 35 . There was one outlier (ASW individual NA20314) when analyzing 141 the African tracts, which was expected as this individual has no African ancestry. There 142 were 8 outliers (PUR HG00731, PUR HG00732, ACB HG01880, ACB HG01882, PEL 143 HG01944, ACB HG02497, ASW NA20320, ASW NA20321) when analyzing the 144 European tracts. Some of these individuals had minimal European ancestry, had South 145 or East Asian ancestry misclassified as European ancestry resulting from a limited 3-146 way ancestry reference panel, or were unexpected outliers. As described in the 147 PCAmask manual, a handful of major outliers sometimes occur. As AS-PCA is an 148 iterative procedure, we therefore removed the major outliers for each sub-continental 149 analysis and orthogonalized the matrix on this subset. 150
151
Tracts 152
The RFMix output was collapsed into haploid bed files, and "UNK" or unknown ancestry 153 was assigned where the posterior probability of a given ancestry was < 0.90. These 154 collapsed haploid tracts were used to infer admixture timings, quantities, and 155 proportions for the ACB and PEL (new to phase 3) using Tracts 57 . Because the ACB 156 have a very small proportion of Native American ancestry, we fit three 2-way models of 157 admixture, including one model of single-and two models of double-pulse admixture 158 events, using Tracts. In both of the double-pulse admixture models, the model includes 159 an early mixture of African and European ancestry followed by another later pulse of 160 either European or African ancestry. We randomized starting parameters and fit each 161 model 100 times and compared the log-likelihoods of the model fits. The single-pulse 162 and double-pulse model with a second wave of African admixture provided the best fits 163 and reached similar log-likelihoods, with the latter showing a slight improvement in fit. 164
165
We next assessed the fit of 9 different models in Tracts for the PEL 57 , including several 166 two-pulse and three-pulse models. Ordering the populations as NAT, EUR, and AFR, 167 we tested the following models: ppp_ppp, ppp_pxp, ppp_xxp, ppx_xxp, ppx_xxp_ppx, 168 ppx_xxp_pxx, ppx_xxp_pxp, ppx_xxp_xpx, and ppx_xxp_xxp, where the order of each 169 letter corresponds with the order of populations given above, an underscore indicates a 170 distinct migration event with the first event corresponding with the most generations 171 before present, p corresponding with a pulse of the ordered ancestries, and x 172 corresponding with no input from the ordered ancestries. We tested all 9 models 173 preliminarily 3 times, and for all models that converged and were within the top 3 174 models, we subsequently fit each model with 100 starting parameters randomizations. 175 176 Imputation accuracy 177 Imputation accuracy was calculated using a leave-one-out internal validation approach. 178 Two array designs were compared for this analysis: Illumina OmniExpress and 179 Affymetrix Axiom World Array LAT. Sites from these array designs were subset from 180 chromosome 9 of the 1000 Genomes Project Phase 3 release for admixed populations.
9
After fixing these sites, each individual was imputed using the rest of the dataset as a 182 reference panel. 183
184
Overall imputation accuracy was binned by minor allele frequency (0.5-1%, 1-2%, 2-3%, 185 3-4%, 4-5%, 5-10%, 10-20%, 20-30%, 30-40%, 40-50%) comparing the genotyped true 186 alleles to the imputed dosages. A second round of analyses stratified the imputation by 187 local ancestry diplotype, which was estimated as described earlier. associations are in the same region in a GWAS, we performed LD clumping in plink (--197 clump) for all variants with MAF ≥ 0.01 59 , which uses a greedy algorithm ordering SNPs 198 by p-value, then selectively removes SNPs within close proximity and LD in ascending 199 p-value order (i.e. starting with the most significant SNP). As a population cohort with 200 similar LD patterns to the study sets, we used European 1000 Genomes samples (CEU, 201 GBR, FIN, IBS, and TSI). To compute the polygenic risk scores, we considered all 202 SNPs with p-values ≤ 1e-2 in the GWAS study, a window size of 250 kb, and an R 2 203 threshold of 0.5 in Europeans to group SNPs. After obtaining the top clumped signals, 204
we computed scores using the --score flag in plink. 205
206
Polygenic risk score simulations 207
We simulated genotypes in a coalescent framework with msprime v0.4.0 60 for 208 chromosome 20 incorporating a recombination map of GRCh37 and an assumed 209 mutation rate of 2e-8 mutations / (base pair * generation). We used a demographic 210 model previously inferred using 1000 Genomes sequencing data 13 to simulate 211 individuals that reflect European, East Asian, and African population histories. We focus 212 on these populations as the demography has previously been modeled and this avoids 213 the challenges of simulating the geographically heterogeneous 52 and sex-biased 214 process of admixture in the Americas 61 . To imitate a GWAS with European sample bias 215 and evaluate polygenic risk scores in other populations, we simulated 200,000 216
European individuals, 200,000 East Asian, and 200,000 African individuals. Next, we 217 assigned "true" causal effect sizes to m evenly spaced alleles. Specifically, we randomly 218 assigned effect sizes as: 219 220 where the normal distribution is specified by the mean and standard deviation (as in 221 python's numpy package). For all other non-causal sites, the effect size is zero. We 222 then define X as: 223
where the g i are the genotype states (i.e. 0, 1, or 2). To handle varying allele 225 frequencies, potential weak LD between causal sites, ensure a neutral model with 226 random true polygenic risks with respect to allele frequencies, and to obtain the total 227 desired variance, we normalize X as: 228
229
We then compute the true polygenic risk score, as: 230 231 such that the total variance of the scores is h 2 . We also simulated environmental noise 232 and standardize to ensure equal variance between normalized genetic and 233 environmental effects before, defining the environmental effect E as: 234 235 such that the total variance of the environmental effect is 1 -h 2 . We then define the 236 total liability as: 237
238
We assigned 10,000 European individuals at the most extreme end of the liability 239 threshold "case" status assuming a prevalence of 5%. We randomly assigned 10,000 240 different European individuals "control" status. We ran a GWAS with these 10,000 241
European cases and 10,000 European controls, computing Fisher's exact test for all 242
sites with MAF > 0.01. As before for empirical polygenic risk score calculations from real 243 GWAS summary statistics, we clumped these SNPs into LD blocks for all sites with p ≤ 244 1e-2, R 2 ≥ 0.5 in Europeans, and within a window size of 250 kb. We used these SNPs 245 to compute inferred polygenic risk scores as before, summing the product of the log 246 odds ratio and genotype for the true polygenic risk in a cohort of 10,000 simulated 247 European, African, and East Asian individuals (all not included in the simulated GWAS). 248
We compared the true versus inferred polygenic risk scores for these individuals across 249 varying complexities (m = 200, 500, 1000) and heritabilites (h 2 = 0.33, 0.50, 0.67). 250
251
Results 252
Genetic diversity within and between populations in the Americas 253
We first assessed the overall diversity at the global and sub-continental level of the 254 1000 Genomes Project (phase 3) populations 18 using a likelihood model via 255 ADMIXTURE 62 and PCA 63 (Figure S1 and Figure S2 ). The six populations from the 256 Americas demonstrate considerable continental admixture, with genetic ancestry 257 primarily from Europe, Africa, and the Americas, recapitulating previously observed 258 population structure 18 . To quantify continental genetic diversity in these populations, we 259 repeated the analysis using YRI, CEU, and NAT samples 54 as reference panels 260 (population labels and abbreviations in Table S1 ). We observed widely varying 261 continental admixture contributions in the six populations from the Americas at K=3 262 ( Figure 1A and Table S2 ). 3), providing support for the latter hypothesis and providing regional nuance to previous 307 findings 49 . 308
309
We also investigated the African origin of the admixed AFR/AMR populations (ACB and 310 project closer to the YRI and ESN of Nigeria than the GWD, MSL, and LWK populations 313 ( Figure 1C) . This is consistent with slave records and previous genome-wide analyses 314 of African Americans indicating that most sharing occurred in West and West-Central 315 Africa 67-69 . There are subtle differences between the African origins of the ACB and 316 ASW populations (e.g. difference in distance from YRI on AS-PC1 and AS-PC2 p=6.4e-317 6), likely due either to mild island founder effects in the ACB samples or differences in 318 African source populations for enslaved Africans who remained in Barbados versus 319 those who were brought to the US. The Native tracts of ancestry from the AMR 320 populations first separate the southernmost PEL populations from the CLM, MXL, and 321 PUR on AS-PC1, then separate the northernmost MXL from the CLM and PUR on AS-322 PC2, consistent with a north-south cline of divergence among indigenous Native 323 American ancestry (Figure 1G) . 35 ,70 324 325
Impact of continental and sub-continental diversity on disease variant mapping 326
To investigate the role of ancestry in phenotype interpretation from genetic data, we 327 assessed diversity across populations and local ancestries for recently admixed 328 populations across the whole genome and sites from two reference databases: the 329 GWAS catalog and ClinVar pathogenic and likely pathogenic sites. We recapitulate 330 results showing that there is less variation across the genome (both genome-wide and 331 on the Affymetrix 6.0 GWAS array sites used in local ancestry calling) in out-of-Africa 332 versus African populations, but that GWAS variants are more polymorphic in European 333
and Hispanic/Latino populations (Figure S7A-B, Figure S8A-B) . We use a normalized measure of the minor allele frequency, an indicator of the amount of diversity captured 335 in a population, to obtain a background coverage of each population, as done previously 336 (e.g. Figure S4 from phase 3 of the 1000 Genomes Project 18 ). We show that the 337 Affymetrix 6.0 array has a slight European bias (Figure S5A and Figure S6A) . We 338 compared the site frequency spectrum of variants across the genome versus at GWAS 339 catalog sites, and identify elevated allele frequencies at GWAS catalog loci, particularly 340 in populations with more European ancestry (e.g. the EUR, AMR, and SAS super 341 populations, Figure S5C-D) . We further compared heterozygosity (estimated here as 342 2pq) and the site frequency spectrum in recently admixed populations across diploid 343 and haploid local ancestry tracts, respectively. Sites in the GWAS catalog and ClinVar 344 are more and less common than genome-wide variants, respectively (Figure 2) . 345
Whereas heterozygosity across the whole genome is highest in African ancestry tracts, 346 it is consistently the greatest in European ancestry tracts across these databases 347 (Figure 2 and Figure S8C-D) , reflecting a strong bias towards European study 348 participants [1] [2] [3] [4] 18, 71 . These results highlight imbalances in genome interpretability across 349 local ancestry tracts in recently admixed populations and the utility of analyzing these 350 variants jointly with these ancestry tracts over genome-wide ancestry estimates alone. 351
352
We also assessed imputation accuracy across the 3-way admixed populations from the 353 Americas (CLM, MXL, PEL, PUR) for two arrays: the Illumina OmniExpress and the 354 Affymetrix Axiom World Array LAT. Imputation accuracy was estimated as the 355 correlation (r 2 ) between the original genotypes and the imputed dosages. For both array for populations with the largest proportion of European ancestry (PUR) and lowest for 358 populations with the largest proportion of Native American ancestry (PEL, Figure S9A -359 B). We also stratified imputation accuracy by local ancestry tract diplotype within the 360 Americas. Consistently, tracts with at least one Native American ancestry tract had 361 lower imputation accuracy when compared to tracts with only European and/or African 362 ancestry (Figure 3 and Figure S10) . 363 364
Transferability of GWAS findings across populations 365
To quantify the transferability of European-biased genetic studies to other populations, 366 we next used published GWAS summary statistics to infer polygenic risk scores 72 367 across populations for well-studied traits, including height 9 , waist-hip ratio 73 , 368 schizophrenia 10 , type II diabetes 74,75 , and asthma 76 (Figure 4A-D, Figure S11 , 369 Methods). Most of these summary statistics are derived from studies with primarily 370
European cohorts, although GWAS of type II diabetes have been performed in both 371
European-specific cohorts as well as across multi-ethnic cohorts. We identify clear 372 directional inconsistencies in these score inferences. For example, although the height 373 summary statistics show the expected cline of southern/northern cline of increasing 374
European height (FIN, CEU, and GBR populations have significantly higher polygenic 375 risk scores than IBS and TSI, p=1.5e-75, Figure S9A ), polygenic scores for height 376 across super populations show biased predictions. For example, the African populations 377 sampled are genetically predicted to be considerably shorter than all Europeans and 378 minimally taller than East Asians (Figure 4A) , which contradicts empirical observations 379 (with the exception of some indigenous pygmy/pygmoid populations) 77,78 . Additionally, polygenic risk scores for schizophrenia, while at a similar prevalence across populations 381 where it has been well-studied 79 and sharing significant genetic risk across 382 populations 80 , shows considerably decreased scores in Africans compared to all other 383 populations (Figure 4B) . Lastly, the relative order of polygenic risk scores computed for 384 type II diabetes across populations differs depending on whether the summary statistics 385 are derived from a European-specific (Figure 4C) or multi-ethnic (Figure 4D ) cohort. 386 387
Ancestry-specific biases in polygenic risk score estimates 388
We performed coalescent simulations to determine how GWAS signals discovered in 389 one ancestral case/control cohort (i.e. 'single-ancestry' GWAS) are expected to impact 390 polygenic risk score estimates in other populations under neutrality using summary 391 statistics (for details, see Methods). Briefly, we simulated variants according to a 392 previously published demographic model inferred from Africans, East Asians, and 393 Europeans 13 . We specified "causal" alleles and effect sizes randomly, such that each 394 causal variant has evolved neutrally and has a mean effect of zero with the standard 395 deviation equal to the global heritability divided by number of causal variants. We then 396 computed the true polygenic risk for each individual as the product of the estimated 397 effect sizes and genotypes, then standardized the scores across all individuals. We 398 calculated the total liability as the sum of the genetic and random environmental 399 contributions, then identified 10,000 European cases with the most extreme liabilities 400 and 10,000 other European controls. We then computed Fisher's exact tests with this 401
European case-control cohort, then quantified inferred polygenic risk scores as the sum of the product of genotypes and log odds ratios for 10,000 samples per population not 403 included in the GWAS. 404
405
In our simulations and consistent with realistic coalescent models, most variants are 406 rare and population-specific; "causal" variants are sampled from the global site 407 frequency spectrum, resulting in subtle differences in true polygenic risk across 408 populations (Figure S12, Figure 5B-D) . We mirrored standard practices for performing 409 a GWAS and computing polygenic risk scores (see above and Methods). We find that 410 the correlation between true and inferred polygenic risk is generally low (Figure 5A , 411 Figure S13), consistent with limited variance explained by polygenic risk scores from 412 GWAS of these cohort sizes for height (e.g. ~10% of variance explained for a cohort of 413 size 183,727 81 ) and schizophrenia (e.g. ~7% variance explained for a cohort of size 414 36,989 cases and 113,075 controls 10 ). Low correlations in our simulations are most 415 likely because common tag variants are a poor proxy for rare causal variants. As 416 expected, correlations between true and inferred risk within populations are typically 417 highest in the European population (i.e. the population in which variants were 418 discovered, Figure 5A and Figure S13) . Across all populations, the mean Spearman 419 correlations between true and inferred polygenic risk increase with increasing heritability 420 while the standard deviation of these correlations significantly decreases (p=0.05); 421 however, there is considerable within-population heterogeneity resulting in high 422 variation in scores across all populations. We find that in these neutral simulations, a 423 polygenic risk score bias in essentially any direction is possible even when choosing the 424 exact same causal variants, heritability, and varying only fixed effect size (i.e. inferred polygenic risk in Europeans can be higher, lower, or intermediate compared to true risk 426 relative to East Asians or Africans, Figure S12, Figure 5B-D) . 427 428 While causal variants in our simulations are drawn from the global site frequency 429 spectrum and are therefore mostly rare, inferred scores are derived specifically from 430 common variants that are typically much more common in the study population than 431 elsewhere (here Europeans with case/control MAF ≥ 0.01). Consequently, the 432 distribution of mean true polygenic risk across simulation runs for each population are 433 not significantly different (Figure 5E) ; however, inferred risk is considerably less than 434 zero in Europeans (p=1.9e-54, 95% CI=[-84.3, -67.4]), slightly less than zero in East 435
Asians (p=5.9e-5, 95% CI=[-19.1, -6.6]) and not significantly different from zero in 436 Africans, with variance in risk scores decreasing with this trend (Figure 5F) . The scale 437 is orders of magnitude different between the true and inferred unstandardized scores, 438 cautioning that while they are informative on a relative scale (Figure 5A and Figure  439   S11 ), their absolute scale should not be overinterpreted. The inferred risk difference 440 between populations is driven by the increased power to detect minor risk alleles rather 441 than protective alleles in the study population 82 , given the differential selection of cases 442 and controls in the liability threshold model. We demonstrate this empirically in these 443 neutral simulations within the European population (Figure 5G) were included in control cohorts 85 . At the highly complex end of the polygenicity 466 spectrum, we and others have shown that the utility of polygenic risk inferences and the 467 heritable phenotypic variance explained in diverse populations is improved with more 468 diverse cohorts 80, 86 . 469
Standard single-ancestry GWAS typically apply linear mixed model approaches and/or 471 incorporate principal components as covariates to control for confounding from 472 population structure with primarily European-descent cohorts [1] [2] [3] . A key concern when 473 including multiple diverse populations in a GWAS is that there is increasing likelihood of 474 identifying false positive variants associated with disease that are driven by allele 475 frequency differences across ancestries. However, previous studies have analyzed 476 association data for diverse ancestries and replicated findings across ethnicities, 477 assuaging these concerns 7,75,87 . In this study, we show that this ancestry stratification is The transferability of GWAS is aided by the inclusion of diverse populations 89 . We have 494
shown that European discovery biases in GWAS are recapitulated in local ancestry 495 tracts in admixed samples. We have quantified GWAS study biases in ancestral 496 populations and shown that GWAS variants are at lower frequency specifically within 497 African and Native tracts and higher frequency in European tracts in admixed American 498 populations. Imputation accuracy is also stratified across diverged ancestries, including 499 across local ancestries in admixed populations. With decreased imputation accuracy 500 especially on Native American tracts, there is decreased power for potential ancestry-501 specific associations. This differentially limits conclusions for GWAS in an admixed 502 population in a two-pronged manner: the ability to capture variation and the power to 503 estimate associations. 504
505
As GWAS scale to sample sizes on the order of hundreds of thousands to millions, 506 genetic risk prediction accuracy at the individual level improves 90 . However, we show 507 that the utility of polygenic risk scores computed using GWAS summary statistics are 508 dependent on genetic similarity to the discovery cohort. BLUP risk prediction methods 509 have been proposed to improve risk scores, but they require access to raw genetic data 510 typically from very large datasets, are also dependent on LD structure in the study 511 population, and only offer modest improvements in prediction accuracy 91 . Furthermore, 512 polygenic risk scores contain a mix of true positives (which have the bias described We have demonstrated that polygenic risk computed from summary statistics in a 518 single-ancestry cohort can be biased in essentially any direction across diverse 519 populations simply as a result of genetic drift, limiting their interpretability; directional 520 selection is expected to bias polygenic risk inferences even more. Because biases arise 521 from genetic drift alone, we recommend: 1) avoiding interpretations from polygenic risk 522 score differences extrapolated across populations, as these are likely confounded by 523 latent population structure that is not properly corrected for with current methods, 2) 524 mean-centering polygenic risk scores for each population, and 3) computing polygenic 525 risk scores in populations with similar demographic histories as the study sample to 526 ensure maximal predictive power. Further, additional methods that account for local 527 ancestry in genetic risk prediction to incorporate different ancestral linkage 528 disequilibrium and allele frequencies are needed. This study demonstrates the utility of 529 disentangling ancestry tracts in recently admixed populations for inferring recent 530 demographic history and identifying ancestry-stratified analytical biases; we also 531 motivate the need to include more ancestrally diverse cohorts in GWAS to ensure that 532 health disparities arising from genetic risk prediction do not become pervasive in 533 individuals of admixed and non-European descent. 
